[ Price : $8.95]
FDA grants an orphan drug designation to the controversial Burzynski Research Institute for its antineoplaston A10 and antineoplas...[ Price : $8.95]
BIO and Merck recommend changes to clarify and improve FDAs draft guidance on End-of-Phase-2 meetings.[ Price : $8.95]
Questcor Pharmaceuticals resubmits a supplemental NDA seeking approval to market its H.P. Acthar Gel for treating infantile spasms...[ Price : $8.95]
In a just-released Warning Letter, FDAs Detroit District Office cites fast-rising generic drug maker Caraco for significant repeat...[ Price : $8.95]
ViroPharma submits a supplemental BLA for Cinryze C1 Inhibitor (human) seeking approval as a treatment for acute hereditary angioe...[ Price : $8.95]
CDER issues a question-and-answer document on Medication Guides for Procrit, Epogen, and Aranesp.[ Price : $8.95]
FDA orders Pharmion to revise Innoheps labeling to reflect an interim finding from a study, stopped in February, of an increase i...[ Price : $8.95]
Bayer agrees to a $97.5 million payment and a corporate integrity agreement to resolve false claim allegations on consumer diabeti...